Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Baxter
Merck
Express Scripts
Colorcon

Anticipate Change

… around branded drug lifecycle management and generic entry
with accurate, objective, and timely intelligence

DrugPatentWatch cited by CNN, NEJM, Nature Journals, and more …

Solutions designed for all your needs

Reliable primary data + expert analysis. We provide answers for your burning questions

→ See why others have switched

Automated Reports
Stop Wasting Time & Money

How much time are you wasting on repetitive tasks?

DrugPatentWatch can take the load off of your team.

Anticipate Generic Drug Launch
Stop Guessing!

Will a generic version of a drug launch? And when?

Expert analysis based on objective data.

What our Clients Say

 Quick and easy to understand summaries, along with all the necessary links for further analysis. 

Mid-Market Pharmaceutical Analyst

Automated Reports

Automated Reports & Custom Dashboards

  • Do more with less staff
  • Take the load off your team
  • Automate processes and focus on growing your business
Find Generic Drug Entry Opportunities

Find Generic Drug Entry Opportunities

  • Inform portfolio management decisions
  • Sector landscaping and due diligence
  • Track drugs in development and explore new indications for existing drugs
Drug Patent Litigation

Get Confidential Royalty and Settlement Terms

  • Study failed patent challenges to develop a better strategy
  • Collect competitive intelligence by examining contractual disputes
  • Track litigation to anticipate early generic entry
Drug Prices

Find and Evaluate Business Opportunities

  • Assess levels of generic competition
  • Use drug price ranges to evaluate price elasticity
  • Determine optimal prices before launch
Drug Sales Histories and Profiles

Refine Your Market-Entry Strategy

  • Assess market potential through historic sales figures
  • Evaluate buyer power with data on reimbursement segmentation
  • Align distribution methods with information on where and how drugs are purchased
Global Drug Patents in 134 Countries

Global Drug Patents

  • Drug Patents in 134 Countries
  • Evaluate branded and generic market opportunities globally
Track 505(b)(2) entrants

Monitor 505(b)(2) and biosimilar activity

  • Anticipate 505(b)(2) and biosimilar approvals
  • Track OTC-switches, new formulations, biosimilars, and other drug improvements
  • Strengthen new formulation patents by studying prior claims and litigation

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
McKinsey
Moodys
Colorcon
Boehringer Ingelheim